Ristau, Johannes <br/><br/>
RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activity.  [electronic resource] 

 -  Cell death & disease  11 2019 
 - 845 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-4889 
<br/><br/><label>Standard No.: </label>10.1038/s41419-019-2074-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents<br/>Apoptosis<br/>Breast Neoplasms--metabolism<br/>DNA-Binding Proteins--genetics<br/>Eukaryotic Initiation Factor-2--genetics<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>MCF-7 Cells<br/>Neoplasm Proteins--genetics<br/>Phosphorylation<br/>Protein Biosynthesis<br/>RNA, Messenger--genetics<br/>Reactive Oxygen Species--metabolism<br/>Signal Transduction<br/>Tumor Suppressor Protein p53--genetics<br/>eIF-2 Kinase--metabolism